What This Evolv Insider Sale Signals to Long-Term Investors as Revenue Jumped 45%
An Evolv Technologies director sold 80,745 shares for about $480,000 at $5.94 per share on July 15, 2026. This disposition reduced Ellenbogen's direct Class A common stock holdings by 4%, while total beneficial ownership remains at about 2.2 million shares.